ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 168

Positive Association Between Tomato Consumption and Serum Urate: Investigating an Anecdotal Trigger of Gout Flares

Tony R. Merriman1, Nicola Dalbeth2, Peter B. B. Jones3, Lisa K. Stamp4, Murray Cadzow5, Ruth Topless1 and Tanya Flynn5, 1Department of Biochemistry, University of Otago, Dunedin, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3Medicine, Waikato Clinical School, Waikato Hospital, Hamilton, New Zealand, 4Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand, 5University of Otago, Dunedin, New Zealand

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Gout and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Gout is characterised by intermittent flares of inflammation in response to monosodium urate crystals in the joints. Gout flares can be triggered by dietary factors that raise serum urate. Tomato consumption is an anecdotal trigger of gout flares. This study aimed to measure the frequency of tomato consumption as a self-reported trigger of gout flares in a New Zealand gout sample set, and to use publically available data to test the hypothesis that tomato consumption is associated with levels of serum urate. 

Methods: 1324 New Zealand people (of Māori, Pacific Island, European or other ancestry) with clinically ascertained gout were asked about dietary triggers of gout. European individuals from the Atherosclerosis Risk In Communities (ARIC, n=7517), Cardiovascular Health Study (CHS, n=2151) and Framingham Heart Study (FHS, n=3052) were used to test for association between serum urate and self-reported tomato intake using two models. Model 1 was adjusted for age, BMI, average calorie intake (kcal/day), principal components analysis vectors 1 and 2 from genome-wide genotype data and model 2 additionally adjusted for meat, seafood/fish, sugar sweetened soft drinks/juices, dairy products, coffee, vitamin C and alcohol consumption.

Results: At least one dietary trigger was reported by 970/1324 (73.3%) of the New Zealand participants with gout. Tomatoes as a dietary trigger was mentioned by 178/970 (18%) participants, making this the 4th most commonly reported dietary trigger in New Zealand men and women. Seafood or fish (634/970; 65%), alcohol (501/970; 52%) and red meat (374/970; 39%) were more frequently reported than tomatoes.  In the analysis of the ARIC, CHS and FHS datasets, there was association between tomato intake and serum urate levels (β=0.66 μmolL-1 per weekly serving; P=0.006), which was evident in both men and women (Table; Model 1). This association was also maintained after adjustment for consumption of all other urate associated dietary exposures (all: β=0.66 μmolL-1, P=0.008) (Table; Model 2).

Conclusion: Tomatoes are a common self-reported trigger of gout flares. Whilst our descriptive and observational data are unable to support the claim that tomato consumption is a trigger of gout attacks, the positive association between tomato consumption and serum urate levels suggests that the self-reporting of tomatoes as a dietary trigger by people with gout has a biological basis.

Table 1: Association Between Serum Urate Levels (μmolL-1) And Tomato Consumption (serves/week) in the European meta-analysis combined cohort

 

Model 1

 

Model 2

 

β [95% CI]

P

Het P

 

β [95% CI]

P

Het P

Men

 

0.84

[0.06; 1.62]

0.035

0.15

 

0.67

[-0.12; 1.45]

0.099

0.11

Women1

 

0.59

[0.02; 1.16]

0.041

0.51

 

0.63

[0.05; 1.22]

0.035

0.78

All2

 

0.664

[0.19; 1.13]

0.006

0.54

 

0.66

[0.17; 1.14]

0.008

0.33

 

 

 

 

 

 

1Adjusted for menopause status.

2Adjusted for sex and menopause status.


Disclosure:

T. R. Merriman,
None;

N. Dalbeth,

Ardea,

5,

AstraZeneca,

5,

Takeda,

5,

Metabolex,

5,

Menarini,

8,

Savient,

8,

Novartis Pharmaceutical Corporation,

8,

Fonterra,

2,

Novartis Pharmaceutical Corporation,

2,

Ardea,

2,

Fonterra,

9;

P. B. B. Jones,
None;

L. K. Stamp,

Astra Zenec,

5,

Abbvie,

9,

PHARMAC,

6;

M. Cadzow,
None;

R. Topless,
None;

T. Flynn,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/positive-association-between-tomato-consumption-and-serum-urate-investigating-an-anecdotal-trigger-of-gout-flares/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology